Pharma Tech
Sep 1, 2026, 1:59 PM
Why CMC readiness is becoming central to biopharma licensing deals
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
Read moreNews
Google News
Pharmaceutical Commerce
The Times of India
Contract Pharma
Cleanroom Technology
pharmtech.com
Pharma Tech
Sep 1, 2026, 1:59 PM
CMC readiness is becoming critical in biopharma licensing as partners demand proof an asset can be transferred, scaled and supplied
Read morePharmaShots
Sep 1, 2026, 12:30 PM
Shots: Ref: Cortec | Image: Cortec | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post CorTec Receives Second FDA Breakthrough Device Designation for Brain Interchange system appeared first on PharmaShots.
Read morePharmaShots
Sep 1, 2026, 12:30 PM
Shots: Company: Biocon Product: Yesafili Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Fresenius Kabi & Dr Reddy’s Laboratories Product: Rituximab Active Ingredient: Rituximab Reference Product: Rituxan Reference Product Company: Genentech & Biogen Disease: All Approved Indications Date: Aug 03, 2026 Shots: Company: Samsung Bioepis Product: Opuviz Active Ingredient: Aflibercept Reference Product: Eylea Reference Product Company: Bayer Disease: All Approved Indications Date: Aug 10, 2026 Shots: … The post Key Biosimilars Events of August 2026 appeared first on PharmaShots.
ET Pharma
Sep 1, 2026, 12:16 PM
Under the agreement, the chinese drugmaker is entitled to receive up to $123 million in upfront, development and regulatory milestone along with double-digit royalties on annual sales.
Read moreExpress Pharma
Sep 1, 2026, 11:54 AM
In a regulatory filing, the company said the transaction was completed on August 31, 2026 The post Mankind Pharma sells Broadway Hospitality stake for Rs 49 crore appeared first on Express Pharma.
Read morePharmaShots
Sep 1, 2026, 11:30 AM
Shots: Ref: Globenewswire | Image: AstraZeneca & Hutchmed | Press Release PharmaShots, your go-to media platform for customized news ranging across multiple indications. For more information, connect with us at connect@pharmashots.com The post HUTCHMED Reports P-III Trial Data on Orpathys + Tagrisso for Previously Untreated MET-Overexpressing EGFRm NSCLC appeared first on PharmaShots.
Read more